173 related articles for article (PubMed ID: 16707059)
41. Guillain-Barré syndrome: association with Campylobacter jejuni and Mycoplasma pneumoniae infections in India.
Gorthi SP; Kapoor L; Chaudhry R; Sharma N; Perez-Perez GI; Panigrahi P; Behari M
Natl Med J India; 2006; 19(3):137-9. PubMed ID: 16836263
[TBL] [Abstract][Full Text] [Related]
42. Campylobacter jejuni capsular genotypes are related to Guillain-Barré syndrome.
Heikema AP; Islam Z; Horst-Kreft D; Huizinga R; Jacobs BC; Wagenaar JA; Poly F; Guerry P; van Belkum A; Parker CT; Endtz HP
Clin Microbiol Infect; 2015 Sep; 21(9):852.e1-9. PubMed ID: 26070960
[TBL] [Abstract][Full Text] [Related]
43. Association between Campylobacter infection and Guillain-Barré syndrome.
Allos BM
J Infect Dis; 1997 Dec; 176 Suppl 2():S125-8. PubMed ID: 9396695
[TBL] [Abstract][Full Text] [Related]
44. Campylobacter jejuni infection during pregnancy: long-term consequences of associated bacteremia, Guillain-Barré syndrome, and reactive arthritist.
Smith JL
J Food Prot; 2002 Apr; 65(4):696-708. PubMed ID: 11952223
[TBL] [Abstract][Full Text] [Related]
45. Association study between an outbreak of Guillain-Barre syndrome in Jilin, China, and preceding Campylobacter jejuni infection.
Zhang M; Li Q; He L; Meng F; Gu Y; Zheng M; Gong Y; Wang P; Ruan F; Zhou L; Wu J; Chen L; Fitzgerald C; Zhang J
Foodborne Pathog Dis; 2010 Aug; 7(8):913-9. PubMed ID: 20455754
[TBL] [Abstract][Full Text] [Related]
46. Campylobacter jejuni infection in Guillain-Barré syndrome: a prospective case control study in a tertiary care hospital.
Sharma A; Lal V; Modi M; Vaishnavi C; Prabhakar S
Neurol India; 2011; 59(5):717-21. PubMed ID: 22019657
[TBL] [Abstract][Full Text] [Related]
47. Detection of preceding Campylobacter jejuni infection by polymerase chain reaction in patients with Guillain-Barré syndrome.
Sinha S; Prasad KN; Pradhan S; Jain D; Jha S
Trans R Soc Trop Med Hyg; 2004 Jun; 98(6):342-6. PubMed ID: 15099989
[TBL] [Abstract][Full Text] [Related]
48. Post-Campylobacter Guillain Barré Syndrome in the USA: secondary analysis of surveillance data collected during the 2009-2010 novel Influenza A (H1N1) vaccination campaign.
Halpin AL; Gu W; Wise ME; Sejvar JJ; Hoekstra RM; Mahon BE
Epidemiol Infect; 2018 Oct; 146(13):1740-1745. PubMed ID: 29986777
[TBL] [Abstract][Full Text] [Related]
49. Guillain-Barré syndrome following primary cytomegalovirus infection: a prospective cohort study.
Orlikowski D; Porcher R; Sivadon-Tardy V; Quincampoix JC; Raphaël JC; Durand MC; Sharshar T; Roussi J; Caudie C; Annane D; Rozenberg F; Leruez-Ville M; Gaillard JL; Gault E
Clin Infect Dis; 2011 Apr; 52(7):837-44. PubMed ID: 21427390
[TBL] [Abstract][Full Text] [Related]
50. Campylobacter jejuni cst-II polymorphisms and association with development of Guillain-Barré syndrome.
Koga M; Yuki N
Neurology; 2007 Oct; 69(17):1727-8; author reply 1728. PubMed ID: 17954791
[No Abstract] [Full Text] [Related]
51. [A case of Guillain-Barré syndrome after Campylobacter jejuni enterocolitis: anti-ganglioside antibody levels with or without Guillain-Barré syndrome].
Watanabe H; Shindo K; Nakamura Y; Nagamatsu M; Shiozawa Z; Kusunoki S
Rinsho Shinkeigaku; 2001 Sep; 41(9):625-7. PubMed ID: 11968750
[TBL] [Abstract][Full Text] [Related]
52. Immunoglobulin KM genes in Guillain-Barré syndrome.
Pandey JP; Vedeler CA
Neurogenetics; 2003 Apr; 4(3):147-9. PubMed ID: 12736802
[TBL] [Abstract][Full Text] [Related]
53. Sensory Guillain-Barré syndrome after Campylobacter jejuni infection.
Rajabally YA; Kass-Hout T; Wilson P; Damian MS
Eur J Neurol; 2007 Mar; 14(3):e11-2. PubMed ID: 17355531
[No Abstract] [Full Text] [Related]
54. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
Prendergast MM; Moran AP
J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
[TBL] [Abstract][Full Text] [Related]
55. The role of cytomegalovirus, Haemophilus influenzae and Epstein Barr virus in Guillain Barre syndrome.
Nafissi S; Vahabi Z; Sadeghi Ghahar M; Amirzargar AA; Naderi S
Acta Med Iran; 2013 Jul; 51(6):372-6. PubMed ID: 23852841
[TBL] [Abstract][Full Text] [Related]
56. Fulminant Guillain-Barrè syndrome after Campylobacter jejuni enteritis and anti-ganglioside antibody.
Saito T
Intern Med; 2002 Oct; 41(10):760-1. PubMed ID: 12412991
[No Abstract] [Full Text] [Related]
57. The demyelination neurophysiological criteria can be misleading in Campylobacter jejuni-related Guillain-Barré syndrome.
Kokubun N; Shahrizaila N; Koga M; Hirata K; Yuki N
Clin Neurophysiol; 2013 Aug; 124(8):1671-9. PubMed ID: 23514735
[TBL] [Abstract][Full Text] [Related]
58. Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barré and Fisher syndromes in Japan.
Takahashi M; Koga M; Yokoyama K; Yuki N
J Clin Microbiol; 2005 Jan; 43(1):335-9. PubMed ID: 15634991
[TBL] [Abstract][Full Text] [Related]
59. [Guillain-barré syndrome associated Campylobacter jejuni serotype Penner 2: a case report].
Watanabe M; Kinoshita I; Hujimoto M; Nakane S; Motomura M; Nakamura T; Kusunoki S; Takahashi M; Saitoh K
No To Shinkei; 2001 Aug; 53(8):759-62. PubMed ID: 11577419
[TBL] [Abstract][Full Text] [Related]
60. Association of Campylobacter jejuni infection and GuillainBarré syndrome: a cohort study in the northwest of Iran.
Barzegar M; Alizadeh A; Toopchizadeh V; Dastgiri S; Majidi J
Turk J Pediatr; 2008; 50(5):443-8. PubMed ID: 19102048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
